Literature DB >> 1120544

Cell-mediated immunity in diabetes mellitus; lymphocyte transformation by insulin and insulin fragments in insulin-treated and newly-diagnosed diabetes.

A C MacCuish, J Jordan, C J Campbell, L J Duncan, W J Irvine.   

Abstract

Using a radioisotope labeling technic, the ability of bovine and porcine insulin antigens to induce lymphocyte transformation was tested with cells from the peripheral blood of thirty nondiabetic controls, fifty established insulin-dependent diabetics with no evidence of insulin allergy, and ten newly diagnosed diabetics (five untreated, five insulin-treated for less than three weeks). Lymphocytes from twenty-six (42 per cent) of the diabetics showed significant blastogenesis to bovine or porcine insulin, as compared with two (7 per cent) of controls; the phenomenon was shown by both established and newly diagnosed patients including four who had never recieved insulin. The results indicate that cellular hypersensitivity to insulin, as judged by an in vitro test, is relatively common in insulin-treated diabetics without in vivo evidence of allergy, and suggest that hypersensitivity may also be present in untreated diabetics. Lymphocytes from twenty-one of the twenty-six diabetics who responded to intact insulin were further tested using bovine and porcine insulin A chain bovine B chain as antigens. The A chain of either insulin induced significant blastogenesis in only one diabetic but bovine B chain induced significant blastogenesis in fourteen (67 per cent) of the patients tested. These results suggest that B chain is the major antigenic site determining cellular hypersensitivity to insulin. Diabetes 24:36-43, January, 1975.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1120544     DOI: 10.2337/diab.24.1.36

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  14 in total

Review 1.  Molecular aspects of type 1 diabetes.

Authors:  M A Kelly; M L Rayner; C H Mijovic; A H Barnett
Journal:  Mol Pathol       Date:  2003-02

2.  Immunoregulatory dysfunctions in type I diabetes: natural and antibody-dependent cellular cytotoxic activities.

Authors:  M P Nair; E W Lewis; S A Schwartz
Journal:  J Clin Immunol       Date:  1986-09       Impact factor: 8.317

Review 3.  Multiple immunological abnormalities in patients with type 1 (insulin-dependent) diabetes mellitus.

Authors:  D W Drell; A L Notkins
Journal:  Diabetologia       Date:  1987-03       Impact factor: 10.122

4.  Cellular cytotoxicity to membrane-associated insulin in an autologous system.

Authors:  E R Richens; M E Seward; R W Groves
Journal:  Acta Diabetol Lat       Date:  1985 Jan-Mar

5.  Lymphocyte transformation by insulin and insulin-zinc suspensions.

Authors:  P Diem; H Spengler; A L de Weck
Journal:  Clin Exp Immunol       Date:  1982-10       Impact factor: 4.330

Review 6.  The role of immunotherapy in type I diabetes mellitus.

Authors:  M E Geffner; B M Lippe
Journal:  West J Med       Date:  1987-03

7.  The human cellular immune response to insulin: a study in unexposed control subjects and type I diabetic patients on acute and chronic treatment.

Authors:  E R Richens; M E Seward; W A Luqman; M Hartog
Journal:  Acta Diabetol Lat       Date:  1986 Oct-Dec

8.  Immune response in the mutant diabetic C57BL/Ks-dt+ mouse. Discrepancies between in vitro and in vivo immunological assays.

Authors:  G Fernandes; B S Handwerger; E J Yunis; D M Brown
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

9.  Autoimmune responses to the beta cell autoantigen, insulin, and the INS VNTR-IDDM2 locus.

Authors:  E Sarugeri; N Dozio; C Belloni; F Meschi; M R Pastore; E Bonifacio
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

10.  Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23).

Authors:  D Daniel; D R Wegmann
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.